• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性淋巴细胞白血病患者T系白血病原始细胞的自然杀伤及抗体依赖性细胞毒性作用

Natural killing and antibody-dependent cytotoxicity by T leukaemic blasts from acute lymphoblastic leukaemia.

作者信息

Gupta S, Fernandes G

出版信息

Scand J Immunol. 1982 Dec;16(6):477-80. doi: 10.1111/j.1365-3083.1982.tb00748.x.

DOI:10.1111/j.1365-3083.1982.tb00748.x
PMID:6984221
Abstract

Bone marrow T leukaemic blasts from four patients with T-cell acute lymphoblastic leukaemia (ALL) were examined as effectors in natural killing (NK) and antibody-dependent cytotoxicity (ADCC). T leukaemic blasts demonstrated both Nk (against K-562 cells as targets) and ADCC (against chicken erythrocytes (CRBC) and cells of SB cell line as targets). NK activity and ADCC (against SB cells) were comparable to NK and ADCC (against SB cells) of peripheral blood T cells from healthy controls. ADCC against CRBC by leukaemic blasts was lower than that of peripheral T cells from normal controls. Of leukaemic blasts 20-42% possessed IgG Fc receptors. This study demonstrates that T leukaemic blasts are effectors in NK and ADCC assays.

摘要

对4例T细胞急性淋巴细胞白血病(ALL)患者的骨髓T白血病原始细胞作为自然杀伤(NK)和抗体依赖性细胞毒性(ADCC)的效应细胞进行了检测。T白血病原始细胞表现出NK活性(以K-562细胞为靶标)和ADCC活性(以鸡红细胞(CRBC)和SB细胞系细胞为靶标)。NK活性和ADCC活性(针对SB细胞)与健康对照外周血T细胞的NK活性和ADCC活性(针对SB细胞)相当。白血病原始细胞针对CRBC的ADCC活性低于正常对照的外周T细胞。20% - 42%的白血病原始细胞具有IgG Fc受体。本研究表明,T白血病原始细胞在NK和ADCC检测中是效应细胞。

相似文献

1
Natural killing and antibody-dependent cytotoxicity by T leukaemic blasts from acute lymphoblastic leukaemia.急性淋巴细胞白血病患者T系白血病原始细胞的自然杀伤及抗体依赖性细胞毒性作用
Scand J Immunol. 1982 Dec;16(6):477-80. doi: 10.1111/j.1365-3083.1982.tb00748.x.
2
Augmentation of human K-cell activity with interferon.用干扰素增强人K细胞活性。
Scand J Immunol. 1980;12(5):365-9. doi: 10.1111/j.1365-3083.1980.tb00079.x.
3
Malignant monoblasts can function as effector cells in natural killer cell and antibody-dependent cellular cytotoxicity assays.恶性单核母细胞在自然杀伤细胞和抗体依赖性细胞毒性试验中可作为效应细胞发挥作用。
Blood. 1981 May;57(5):972-4.
4
T-cell acute lymphoblastic leukemia with natural killer cell phenotype.具有自然杀伤细胞表型的T细胞急性淋巴细胞白血病
Am J Hematol. 1986 Aug;22(4):355-64. doi: 10.1002/ajh.2830220404.
5
Natural killer and antibody-dependent cytotoxic activities in T cell chronic lymphocytic leukemia.T细胞慢性淋巴细胞白血病中的自然杀伤和抗体依赖性细胞毒性活性
J Clin Lab Immunol. 1983 Nov;12(3):155-7.
6
Heterogeneity of human lymphocyte Fc receptors: studies using heat-aggregated and antigen-complexed IgG from human, rabbit, guinea pig, horse and goat.人淋巴细胞Fc受体的异质性:使用来自人、兔、豚鼠、马和山羊的热聚集IgG及抗原复合IgG的研究
Comp Immunol Microbiol Infect Dis. 1982;5(4):483-99. doi: 10.1016/0147-9571(82)90074-1.
7
Natural killing and antibody-dependent cytotoxicity by lymphocyte subpopulations in young and aging humans.年轻和老年人体内淋巴细胞亚群的自然杀伤及抗体依赖性细胞毒性作用
J Clin Immunol. 1981 Jul;1(3):141-8. doi: 10.1007/BF00922755.
8
Ontogeny of natural killer cell activity and antibody dependent cell mediated cytotoxicity in pigs.猪自然杀伤细胞活性及抗体依赖性细胞介导的细胞毒性的个体发生
Dev Comp Immunol. 1986 Summer;10(3):405-18. doi: 10.1016/0145-305x(86)90030-3.
9
Stimulating capacity of blast cells from patients with chronic myelocytic leukaemia, in blastic crisis in 'one-way' mixed lymphoycte reaction: lack of evidence for T lymphoblastic conversion.慢性粒细胞白血病患者处于原始细胞危象时原始细胞在“单向”混合淋巴细胞反应中的刺激能力:缺乏T淋巴母细胞转化的证据
Immunology. 1978 Aug;35(2):299-305.
10
Natural and antibody-dependent cellular cytotoxicity in tumour-adherent T lymphocytes: expression of Fc receptors and of a human T-subgroup-specific antigen.肿瘤黏附性T淋巴细胞中的自然细胞毒性和抗体依赖性细胞毒性:Fc受体及一种人类T亚群特异性抗原的表达
Scand J Immunol. 1981 May;15(5):483-92. doi: 10.1111/j.1365-3083.1982.tb00674.x.

引用本文的文献

1
Extremely high levels of natural killer cells in angioimmunoblastic lymphadenopathy.
J Clin Immunol. 1983 Oct;3(4):375-81. doi: 10.1007/BF00915799.